B cell responses to conjugate and polysaccharide meningococcal vaccines
<p>The primary approach to the control of meningococcal disease remains effective vaccination programmes in susceptible populations. Vaccines against serogroups A, C, W and Y offer broad protection against meningococci and both polysaccharide and conjugate quadrivalent vaccines are licensed fo...
Hlavní autor: | Ramasamy, M |
---|---|
Další autoři: | Pollard, A |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
2012
|
Témata: |
Podobné jednotky
-
Quadrivalent meningococcal conjugate vaccines
Autor: Pace, D, a další
Vydáno: (2009) -
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
Autor: Pollard, A, a další
Vydáno: (2004) -
Global epidemiology of meningococcal disease and vaccine efficacy
Autor: Pollard, A
Vydáno: (2004) -
Impact of serogroup A meningococcal conjugate vaccine for Africa
Autor: James M. Stuart
Vydáno: (2018-05-01) -
Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
Autor: Pollard, A, a další
Vydáno: (2009)